Estrogen receptor‐α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells

Acquired tamoxifen (TAM) resistance limits the therapeutic benefit of TAM in patients with hormone‐dependent breast cancer. The switch from estrogen‐dependent to growth factor‐dependent growth is a critical step in this process. However, the molecular mechanisms underlying this switch remain poorly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Li, Guangliang, Zhang, Jing, Jin, Ketao, He, Kuifeng, Zheng, Yi, Xu, Xin, Wang, Haohao, Wang, Haiyong, Li, Zhongqi, Yu, Xiongfei, Teng, Xiaodong, Cao, Jiang, Teng, Lisong
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2013
Assuntos:
Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528464/
https://ncbi.nlm.nih.gov/pubmed/23499324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2013.02.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados